PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 23, 2026European Heart Journal800 citationsOpen Access

Mendelian randomization of blood lipids for coronary heart disease

View Full Paper
MHMichael V. HolmesFAFolkert W. AsselbergsTPTom Palmer

Key Result

Genetically determined triglycerides have a causal effect on coronary heart disease risk, but a causal role for HDL cholesterol remains less certain.

Key Points

  • This study investigates the causal effects of high-density lipoprotein cholesterol and triglycerides on coronary heart disease risk using genetic data.
  • Developed weighted allele scores based on SNPs linked to HDL-C and triglycerides.
  • Conducted Mendelian randomization analyses in 17 studies with 62,199 participants.
  • Used both unrestricted and restricted SNP scores for HDL-C and triglycerides.
  • HDL-C unrestricted score showed an association with CHD (OR: 0.53; 95% CI: 0.40, 0.70) per 1 mmol/L increase.
  • Triglycerides scores demonstrated a significant association with CHD (OR: 1.62; 95% CI: 1.24, 2.11) per 1-log unit increment.
  • The causal role of HDL-C remains uncertain compared to triglycerides, which showed consistent associations.

Structured PICO

Do genetically determined levels of triglycerides and HDL-C affect the risk of coronary heart disease?

I
Intervention
Genetically determined blood lipid levels (triglycerides and HDL-C)
O
Outcome
Coronary heart disease (CHD) riskhard clinical

Mendelian randomization supports a causal role for triglycerides, but not definitively for HDL-C, in the development of coronary heart disease.

Abstract

AIMS: To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. METHODS AND RESULTS: We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a prior meta-analysis (threshold P < 2 × 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P ≤ 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestricted allele score (48 SNPs) was associated with CHD (OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75). CONCLUSION: The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Holmes et al. (2014) studied this question. Genetically determined triglycerides have a causal effect on coronary heart disease risk, but a causal role for HDL cholesterol remains less certain.

synapsesocial.com/papers/69ea386cc2ceeb8fbfae7e92https://doi.org/10.1093/eurheartj/eht571
Ask AI
Helpful
Bookmark
Share
View Full Paper